These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

316 related articles for article (PubMed ID: 18425004)

  • 1. Proteomics: present and future implications in neuro-oncology.
    Micallef J; Gajadhar A; Wiley J; DeSouza LV; Michael Siu KW; Guha A
    Neurosurgery; 2008 Mar; 62(3):539-55; discussion 539-55. PubMed ID: 18425004
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Oncoproteomics: current trends and future perspectives.
    Cho WC; Cheng CH
    Expert Rev Proteomics; 2007 Jun; 4(3):401-10. PubMed ID: 17552924
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Recent advances in oncoproteomics.
    Jain KK
    Curr Opin Mol Ther; 2002 Jun; 4(3):203-9. PubMed ID: 12139304
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Current trends in computational inference from mass spectrometry-based proteomics.
    Webb-Robertson BJ; Cannon WR
    Brief Bioinform; 2007 Sep; 8(5):304-17. PubMed ID: 17584764
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A review of current applications of mass spectrometry for neuroproteomics in epilepsy.
    Liu X; Wen F; Yang J; Chen L; Wei YQ
    Mass Spectrom Rev; 2010; 29(2):197-246. PubMed ID: 19598206
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Recent advances in clinical oncoproteomics.
    Jain KK
    J BUON; 2007 Sep; 12 Suppl 1():S31-8. PubMed ID: 17935275
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Proteomics and the haematologist.
    Rees-Unwin KS; Morgan GJ; Davies FE
    Clin Lab Haematol; 2004 Apr; 26(2):77-86. PubMed ID: 15053800
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Proteomics: methodologies and applications in oncology.
    Wouters BG
    Semin Radiat Oncol; 2008 Apr; 18(2):115-25. PubMed ID: 18314066
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Comparative proteomics analysis of human pituitary adenomas: current status and future perspectives.
    Zhan X; Desiderio DM
    Mass Spectrom Rev; 2005; 24(6):783-813. PubMed ID: 15495141
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Strategies for plasma proteomic profiling of cancers.
    Omenn GS
    Proteomics; 2006 Oct; 6(20):5662-73. PubMed ID: 16991194
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Proteomic approaches in cancer risk and response assessment.
    Petricoin EF; Liotta LA
    Trends Mol Med; 2004 Feb; 10(2):59-64. PubMed ID: 15102358
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Proteomic profiling of cancer--opportunities, challenges, and context.
    Arnott D; Emmert-Buck MR
    J Pathol; 2010 Sep; 222(1):16-20. PubMed ID: 20623483
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Mass spectrometry in systems biology: an overview.
    Feng X; Liu X; Luo Q; Liu BF
    Mass Spectrom Rev; 2008; 27(6):635-60. PubMed ID: 18636545
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Proteomics: addressing the challenges of multiple myeloma.
    Ge F; Tao S; Bi L; Zhang Z; Zhang X
    Acta Biochim Biophys Sin (Shanghai); 2011 Feb; 43(2):89-95. PubMed ID: 21212069
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Present possibilities and future development of clinical proteomics].
    Lehmann S; Dupuy A; Peoc'h K; Roche S; Baudin B; Quillard M; Berger F; Briand G; Chwetzoff S; Dine G; Gonzalo P; Dastugue B; Sève M; Siest G; Beaudeux JL
    Ann Biol Clin (Paris); 2007; 65(5):463-71. PubMed ID: 17913666
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Array-based proteomics: mapping of protein circuitries for diagnostics, prognostics, and therapy guidance in cancer.
    Gulmann C; Sheehan KM; Kay EW; Liotta LA; Petricoin EF
    J Pathol; 2006 Apr; 208(5):595-606. PubMed ID: 16518808
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cancer: a proteomic disease.
    Li G; Xiao Z; Liu J; Li C; Li F; Chen Z
    Sci China Life Sci; 2011 May; 54(5):403-8. PubMed ID: 21455689
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Use of proteomics for the identification of novel drug targets in brain diseases.
    Morón JA; Devi LA
    J Neurochem; 2007 Jul; 102(2):306-15. PubMed ID: 17419802
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Probing cellular complexity with proteomics.
    Blackstock W; Rowley A
    Curr Opin Mol Ther; 1999 Dec; 1(6):702-11. PubMed ID: 19629867
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Proteomic analysis of bone cancer: a review of current and future developments.
    Bhattacharyya S; Byrum S; Siegel ER; Suva LJ
    Expert Rev Proteomics; 2007 Jun; 4(3):371-8. PubMed ID: 17552921
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.